Oceania Healthcare Limited — Cyborg Score 6/10

Solid
Aged Care & Retirement Living

Strategic Profile

The company's premium care focus and efficient capital deployment in modern villages are strengthening pricing power, margins, and asset stability. Cost-saving efforts, digitization, and lower interest expenses are set to improve margins and support sustained growth despite sector headwinds.

Cyborg Score Rationale

3 analysts recommend buying the stock with an overall rating of Strong Buy. However, persistent staff cost pressures and high debt levels threaten margin sustainability and financial flexibility amid rising rates. The company shows operational resilience but faces sector headwinds.

Top Insights

  • OCA exceeded both the NZ Healthcare industry and NZ Market returns over the past year
  • Demographic tailwinds support long-term demand, but shifts toward home-based care and dependency on resilient property values may limit future growth
  • The company has 2,600 employees
  • 3 analysts recommend buying with an overall Strong Buy rating

Named Competitors

  • Aged Care Services — New Zealand retirement community operator
  • Aged Care Services — New Zealand and Australian retirement village operator
  • Aged Care Services — New Zealand retirement living provider

Recent Developments

  • (Jan 2026) Trading at NZD 0.910 with 52-week range of NZD 0.570 to 0.930
  • (2024) Revenue was NZD 260.57 million, a decrease of 1.84% from prior year
  • (2024) Earnings decreased 3.36% year-over-year

Open the full interactive Oceania Healthcare Limited report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →